Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2010 2
2011 3
2012 2
2013 1
2014 2
2015 1
2016 3
2017 2
2018 3
2020 4
2021 5
2022 11
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults.
Falsey AR, Williams K, Gymnopoulou E, Bart S, Ervin J, Bastian AR, Menten J, De Paepe E, Vandenberghe S, Chan EKH, Sadoff J, Douoguih M, Callendret B, Comeaux CA, Heijnen E; CYPRESS Investigators. Falsey AR, et al. Among authors: callendret b. N Engl J Med. 2023 Feb 16;388(7):609-620. doi: 10.1056/NEJMoa2207566. N Engl J Med. 2023. PMID: 36791161 Clinical Trial.
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries.
Nguyen-Van-Tam JS, O'Leary M, Martin ET, Heijnen E, Callendret B, Fleischhackl R, Comeaux C, Tran TMP, Weber K. Nguyen-Van-Tam JS, et al. Among authors: callendret b. Eur Respir Rev. 2022 Nov 15;31(166):220105. doi: 10.1183/16000617.0105-2022. Print 2022 Dec 31. Eur Respir Rev. 2022. PMID: 36384703 Free PMC article. Review.
Antibody effector functions are associated with protection from respiratory syncytial virus.
Bartsch YC, Cizmeci D, Kang J, Zohar T, Periasamy S, Mehta N, Tolboom J, Van der Fits L, Sadoff J, Comeaux C, Callendret B, Bukreyev A, Lauffenburger DA, Bastian AR, Alter G. Bartsch YC, et al. Among authors: callendret b. Cell. 2022 Dec 22;185(26):4873-4886.e10. doi: 10.1016/j.cell.2022.11.012. Epub 2022 Dec 12. Cell. 2022. PMID: 36513064 Free article.
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study.
Sadoff J, De Paepe E, DeVincenzo J, Gymnopoulou E, Menten J, Murray B, Rosemary Bastian A, Vandebosch A, Haazen W, Noulin N, Comeaux C, Heijnen E, Eze K, Gilbert A, Lambkin-Williams R, Schuitemaker H, Callendret B. Sadoff J, et al. Among authors: callendret b. J Infect Dis. 2022 Aug 26;226(3):396-406. doi: 10.1093/infdis/jiab003. J Infect Dis. 2022. PMID: 33400792 Free PMC article. Clinical Trial.
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.
Cox F, Saeland E, Thoma A, van den Hoogen W, Tettero L, Drijver J, Vaneman C, van Polanen Y, Ritschel T, Bastian AR, Callendret B, Zahn R, van der Fits L. Cox F, et al. Among authors: callendret b. Vaccines (Basel). 2023 Mar 16;11(3):672. doi: 10.3390/vaccines11030672. Vaccines (Basel). 2023. PMID: 36992257 Free PMC article.
Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine.
Bartsch YC, Cizmeci D, Yuan D, Mehta N, Tolboom J, De Paepe E, van Heesbeen R, Sadoff J, Comeaux CA, Heijnen E, Callendret B, Alter G, Bastian AR. Bartsch YC, et al. Among authors: callendret b. J Virol. 2023 Nov 30;97(11):e0077123. doi: 10.1128/jvi.00771-23. Epub 2023 Oct 30. J Virol. 2023. PMID: 37902399 Free PMC article. Clinical Trial.
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months.
Stuart ASV, Virta M, Williams K, Seppa I, Hartvickson R, Greenland M, Omoruyi E, Bastian AR, Haazen W, Salisch N, Gymnopoulou E, Callendret B, Faust SN, Snape MD, Heijnen E. Stuart ASV, et al. Among authors: callendret b. J Infect Dis. 2022 Dec 28;227(1):71-82. doi: 10.1093/infdis/jiac407. J Infect Dis. 2022. PMID: 36259542 Free PMC article. Clinical Trial.
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF-Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study.
Comeaux CA, Bart S, Bastian AR, Klyashtornyy V, De Paepe E, Omoruyi E, van der Fits L, van Heesbeen R, Heijnen E, Callendret B, Sadoff J. Comeaux CA, et al. Among authors: callendret b. J Infect Dis. 2024 Jan 12;229(1):19-29. doi: 10.1093/infdis/jiad220. J Infect Dis. 2024. PMID: 37433021 Free PMC article. Clinical Trial.
43 results